Biologically-Active Medical Devices Manufactured from Blood Plasma

Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.

News

4/19/13   Can New Plasma-Based Biomaterials Speed Healing of Injured Tissues?   New Rochelle, NY, April 15, 2013—Platelet-rich plasma (PRP) derived from blood contains growth factors and other bioactive molecules that promote he[...]
6/21/11   Tragic Death of Mike Egan June 18   Mike Egan, one of Carmell's newest board members, died tragically on June 18 in a bicycle accident while on vacation in Norway. At the time of the ac[...]
4/24/11   NEWS RELEASE - Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics   Pittsburgh, PA – April 15, 2011 – Carmell Therapeutics, a company that manufactures novel blood plasma-based biomaterials that accelerate the repa[...]